Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAAOI-P for Parkinson's Disease with Dementia
NCT04470037Phase 2Completed
- Sponsor
- China Medical University Hospital
- Start
- Apr 2016
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DAAOI-P in Parkinson's disease dementia (PDD), sponsored by China Medical University Hospital. Started Apr 2016; status: completed.
02
Drugs
DAAOI-P
03
Conditions
Parkinson's disease dementia (PDD)
Beyond the preview
Go deeper on NCT04470037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04470037.